Camlin Fine Sciences Limited — Others, 23-05-2025: Change in Management

Camlin Fine Sciences has announced a board meeting on the financial results for the quarter and half-year. The Board approved audited consolidated and standalone financials for FY 2024-25 with an unmodified audit opinion. New appointments include M/s. ABK & Associates as Cost Auditors, M/s. Mahajan & Aibara as Internal Auditors, and M/s. JHR & Associates as Secretarial Auditors from FY 2025-26. It approved the liquidation of two non-material subsidiaries and the merger of CFS De Mexico Blends into Dresen Quimica to streamline operations. Continuing operations reported standalone PBT of Rs. 11.89 Cr. An embezzlement of Rs. 6.4 Cr was uncovered at a step-down subsidiary, with legal action ongoing. The recently completed rights issue raised Rs. 224.7 Cr, boosting financial strength. EPS from continuing operations stands at Rs. 1.17 (standalone) and Rs. 2.89 (consolidated).